Protagonist Therapeutics Inc buy Capital One Financial Co.
Start price
30.10.23
/
50%
€85.50
Target price
30.10.24
€30.16
Performance (%)
-
End price
31.10.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | -1.156% | -1.156% | 131.081% |
| iShares Core DAX® | 0,42 % | 5,71 % | 4,70 % |
| iShares Nasdaq 100 | 4,10 % | 16,64 % | 38,95 % |
| iShares Nikkei 225® | 4,47 % | 18,34 % | 50,39 % |
| iShares S&P 500 | 1,79 % | 9,64 % | 26,90 % |
Comments by Capital_One_Financia for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $32.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von Capital_One_Financia gewählte maximale Laufzeit wurde überschritten